These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 11093849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.
    Chew DP, Moliterno DJ.
    Cleve Clin J Med; 2001 Dec; 68(12):1017-23. PubMed ID: 11765119
    [Abstract] [Full Text] [Related]

  • 4. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.
    Tcheng JE.
    Am Heart J; 1999 Oct; 138(4 Pt 2):261-2. PubMed ID: 10502231
    [No Abstract] [Full Text] [Related]

  • 5. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Bhatt DL, Topol EJ.
    JAMA; 2000 Sep 27; 284(12):1549-58. PubMed ID: 11000650
    [Abstract] [Full Text] [Related]

  • 6. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Roe MT, Sapp SK, Lincoff AM.
    Cleve Clin J Med; 2000 Feb 27; 67(2):131-40. PubMed ID: 10680279
    [Abstract] [Full Text] [Related]

  • 7. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
    Lincoff AM, Califf RM, Topol EJ.
    J Am Coll Cardiol; 2000 Apr 27; 35(5):1103-15. PubMed ID: 10758948
    [Abstract] [Full Text] [Related]

  • 8. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA.
    Eur Heart J; 1998 Apr 27; 19 Suppl D():D10-21. PubMed ID: 9597518
    [Abstract] [Full Text] [Related]

  • 9. Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.
    Gibson CM, Moynihan JL, Al-Mousa EN, Campsey M, Gandhi R, Murphy S, Mattson S, Ryan KA, Mesley R, Swanson J, Arshad MN, Marble SJ.
    J Thromb Thrombolysis; 1999 Jun 27; 7(3):287-302. PubMed ID: 10375390
    [No Abstract] [Full Text] [Related]

  • 10. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
    Sabatine MS, Jang IK.
    Am J Med; 2000 Aug 15; 109(3):224-37. PubMed ID: 10974186
    [Abstract] [Full Text] [Related]

  • 11. Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
    MacCallum EM, Hanlon SJ, Byrne KH.
    Nursing; 1999 Dec 15; 29(12):34-9; quiz 40. PubMed ID: 10797693
    [No Abstract] [Full Text] [Related]

  • 12. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
    Ronner E, Dykun Y, van den Brand MJ, van der Wieken LR, Simoons ML.
    Eur Heart J; 1998 Nov 15; 19(11):1608-16. PubMed ID: 9857912
    [No Abstract] [Full Text] [Related]

  • 13. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization.
    Lincoff AM.
    Am J Cardiol; 1998 Oct 22; 82(8B):36P-42P. PubMed ID: 9809890
    [Abstract] [Full Text] [Related]

  • 14. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.
    Herz; 2003 Aug 22; 28(5):393-403. PubMed ID: 12928738
    [Abstract] [Full Text] [Related]

  • 15. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Kereiakes DJ, Broderick TM, Roth EM, Whang D, Shimshak T, Runyon JP, Hattemer C, Schneider J, Lacock P, Mueller M, Abbottsmith CW.
    Am J Cardiol; 1999 Aug 15; 84(4):391-5. PubMed ID: 10468074
    [Abstract] [Full Text] [Related]

  • 16. Economic issues in glycoprotein IIb/IIIa receptor therapy.
    Hillegass WB, Newman AR, Raco DL.
    Am Heart J; 1999 Jul 15; 138(1 Pt 2):S24-32. PubMed ID: 10385788
    [Abstract] [Full Text] [Related]

  • 17. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA.
    Am Heart J; 1998 Apr 15; 135(4):S43-55. PubMed ID: 9539495
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
    Hobbach HP, Schuster P.
    Z Kardiol; 2003 Mar 15; 92(3):213-8. PubMed ID: 12658467
    [Abstract] [Full Text] [Related]

  • 19. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
    Berkowitz SD.
    Haemostasis; 2000 Mar 15; 30 Suppl 3():27-43. PubMed ID: 11182626
    [Abstract] [Full Text] [Related]

  • 20. Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
    Vernon SM.
    Cardiol Clin; 2001 May 15; 19(2):235-52, vi. PubMed ID: 11407108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.